Home > Financial Ratios > SOLARA ACTIVE PHARMA SCIENCES

SOLARA ACTIVE PHARMA SCIENCES
EV/Core EBITDA

    Back to All Ratios
AD     Remove this Ad

SOLARA ACTIVE PHARMA SCIENCES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 13.21-25.9613.9033.7213.07

What is the latest EV/Core EBITDA ratio of SOLARA ACTIVE PHARMA SCIENCES ?

The latest EV/Core EBITDA ratio of SOLARA ACTIVE PHARMA SCIENCES is 13.21 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202513.21
Mar2024-25.96
Mar202313.90
Mar202233.72
Mar202113.07

How is EV/Core EBITDA of SOLARA ACTIVE PHARMA SCIENCES Trending?

Years EV/Core EBITDA % Change
Mar2025 13.21
Positive
Mar2024 -25.96
Negative
Mar2023 13.9
-58.78
Mar2022 33.72
158.00
Mar2021 13.07 -

Other Financial Ratios of SOLARA ACTIVE PHARMA SCIENCES


Compare EV/Core EBITDA ratio of peers of SOLARA ACTIVE PHARMA SCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES ₹2,341.3 Cr 3.3% 7.7% -10.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,018.0 Cr -2.3% -8.5% -3% Stock Analytics
DIVIS LABORATORIES ₹162,454.0 Cr 5.3% -3.4% 3.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹140,702.0 Cr 3.7% -4.9% 26% Stock Analytics
DR REDDYS LABORATORIES ₹102,830.0 Cr 1.2% -4.2% 5.3% Stock Analytics
CIPLA ₹99,325.0 Cr 2.4% -7.2% -18.1% Stock Analytics


SOLARA ACTIVE PHARMA SCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOLARA ACTIVE PHARMA SCIENCES

3.3%

7.7%

-10.7%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses